Clinical Trial

Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients

Name: Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients — clinical trial record (NCT07701512)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To assess the effect of Febuxostat on clinical outcomes and biomarkers of oxidative stress and inflammation in patients with conservatively managed intracranial hemorrhage.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-08.

Trial Details

NCT Number	NCT07701512
Lead Sponsor	Tanta University
Conditions	Intracranial Hemorrhage
Enrollment	46 participants
Start Date	2025-11-20
Primary Completion	2026-10-30 (estimated)
Study Completion	2027-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-15